Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1978-05-04
1979-11-06
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
041736303
ABSTRACT:
N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis in mammals.
REFERENCES:
patent: 4036955 (1977-07-01), Okamoto et al.
patent: 4041156 (1977-08-01), Okamoto et al.
patent: 4046876 (1977-09-01), Okamoto et al.
patent: 4055636 (1977-10-01), Okamoto et al.
patent: 4055651 (1977-10-01), Okamoto et al
patent: 4066758 (1978-01-01), Okamoto et al.
patent: 4066759 (1978-01-01), Okamoto et al.
patent: 4069329 (1978-01-01), Okamoto et al.
patent: 4073891 (1978-02-01), Okamoto et al.
patent: 4073892 (1978-02-01), Okamoto et al.
patent: 4073914 (1978-02-01), Kikumoto et al.
patent: 4073916 (1978-02-01), Okamoto et al.
Hijikata Akiko
Kikumoto Ryoji
Ohkubo Kazuo
Okamoto Shosuke
Tamao Yoshikuni
Mitsubishi Chemical Industries Limited
Okamoto Shosuke
Phillips Delbert R.
LandOfFree
N.sup.2 Arylsulfonyl-L-argininamides and the pharmaceutically ac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N.sup.2 Arylsulfonyl-L-argininamides and the pharmaceutically ac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N.sup.2 Arylsulfonyl-L-argininamides and the pharmaceutically ac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-462324